UNI-EN 199:Sale of the share in the capital of the subsidiary SIA „Briz“
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 199 | / | 2021 | |||||||
Date of issue: | 2021-12-23 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Sale of the share in the capital of the subsidiary SIA „Briz“ | |||||||||||
Official market - legal basis | |||||||||||
art. 56. 1. 2 of Act on Public Offering. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
“Sopharma” AD (the Company) notifies that the Board of Directors took a decision for disposal of all the shares (100%) owned by the Company in the capital of the subsidiary SIA Briz, Latvia. The decision follows the strategy to optimize the commercial activity of the company, to improve the performance on all markets and to increase the value for shareholders. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
SFA_2021_BRIZ_EN_espi.pdf SFA_2021_BRIZ_EN_espi.pdf | Sale of the share in the capital of the subsidiary SIA „Briz“ |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2021-12-23 | Ognian Donev | Executive Director |
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 10.3 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.